Top researchers into the use of embryonic stem cells gathered at Yonsei University in Seoul Thursday for a two-day symposium to share their findings.
Participants include 21 scientists from five nations -- the United States, Britain, Australia, Japan and Korea, the Korea Times reported. Among them are Seoul National University Professor Moon Shin-yong, who first cloned embryonic human stem cells in 2003 with his colleague Hwang Woo-suk, and Hal Broxmeyer of Indiana University, who discovered stem cells in umbilical cord blood and transplanted them into leukemia patients in the late 1980s.
Broxmeyer, a world-renowned researcher of blood cell production, was to lecture on the mobilization and homing of blood stem and progenitor cells.
In addition to lectures by the high-profile researchers, the two-day event will feature wide-ranging topics on both embryonic and adult stem cells, the report said.
Stem cells, which have the ability to become regular cells or develop into organs and tissues, are attracting huge interest for their therapeutic potential as well as stirring controversy over the use of human embryos.
Just days ago, U.S. researchers said
they had devised a way of generating stem cells without the use of human embryos.
Copyright 2005 by United Press International
Related stories:
A link between mitochondria and tumor formation in stem cells
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria –a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
Time of day influences yield for pharmacologically stimulated stem cell mobilization
A new study uncovers a previously unrecognized, species-specific impact of circadian rhythms on the production of mobilized stem cells. The research, published by Cell Press in the October 9th issue of the journal
Cell Stem Cell, suggests that when it comes to collecting human stem cells for clinical transplantation, picking the right time of day to harvest cells may result in a greater yield.
Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.
Can stem cells heal damaged hearts? No easy answers, but some signs of hope
Recent studies indicate that infusing hearts with stem cells taken from bone marrow could improve cardiac function after myocardial infarction (tissue damage that results from a heart attack). But in a recent systematic review, Cochrane Researchers concluded that more clinical trials are needed to assess the effectiveness of stem cell therapies for heart patients, as well as studies to establish how these treatments work.
University: Stem-cell study used falsified data
(AP) -- The University of Minnesota has concluded that falsified data were used in a 2001 article published by one of its researchers on adult stem cells. The school is asking that the article be retracted.
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of
Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Healthy blood vessels may prevent fat growth
The cells lining blood vessels are known to be important for maintaining health, but researchers at the Indiana University School of Medicine believe these cells may perform an unsuspected task – controlling the development of fat cells. Their findings are reported in the September issue of the journal
Stem Cells.
'Baby' fat cells may be key to treating obesity
Immature, or "baby," fat cells lurk in the walls of the blood vessels that nourish fatty tissue, just waiting for excess calories to help them grow into the adult monsters responsible for packing on the extra pounds, researchers at UT Southwestern Medical Center have found in mice.